SavedAdd your journal

Journals / Journal of advances in vetbio science and techniques / 2026 / Issue: 2

Network analysis and species-specific siRNA design targeting MMP7 in feline chronic kidney disease

Sinan Vıcıl(TEKİRDAĞ NAMIK KEMAL ÜNİVERSİTESİ)0000-0002-0444-4771
Tuğrul Kırkulak(TEKIRDAG NAMIK KEMAL UNIVERSITY)0009-0009-0239-166X
Pages
—
Publication Date
2026-10-02
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MMP7-siRNA1 showed the most favorable overall profile, including a comparatively favorable Basic Local Alignment Search Tool (BLAST)-based specificity profile, stable duplex formation, low self-folding tendency, and high thermal stability.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic kidney disease (CKD) is a common acquired disorder in older cats and is associated with tubulointerstitial fibrosis, chronic inflammation, hypoxia, oxidative stress, and extracellular matrix (ECM) remodeling.
📊
Key Findings & Data:Matrix metalloproteinase-7 (MMP7), a tubular epithelial-derived endopeptidase, has been implicated in renal fibrotic progression in human and rodent CKD, but remains poorly characterized in Felis catus.
💡
Conclusion & Impact:MMP7-siRNA1 showed the most favorable overall profile, including a comparatively favorable Basic Local Alignment Search Tool (BLAST)-based specificity profile, stable duplex formation, low self-folding tendency, and high thermal stability.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Extracellular matrix remodeling · feline chronic kidney disease · in silico analysis

Abstract

Chronic kidney disease (CKD) is a common acquired disorder in older cats and is associated with tubulointerstitial fibrosis, chronic inflammation, hypoxia, oxidative stress, and extracellular matrix (ECM) remodeling. Matrix metalloproteinase-7 (MMP7), a tubular epithelial-derived endopeptidase, has been implicated in renal fibrotic progression in human and rodent CKD, but remains poorly characterized in Felis catus. This study aimed to characterize the MMP7-associated molecular network in feline CKD and to design species-specific small interfering RNA (siRNA) candidates targeting Felis catus MMP7 using a multi-step in silico workflow. A 27-gene candidate panel representing ECM remodeling, fibrosis, hypoxia, inflammation, inflammasome activation, apoptosis, oxidative stress, and tubular injury was analyzed using Enrichr, STRING v12.0, Cytoscape v3.10.4, and cytoHubba. Functional enrichment analyses showed significant associations with inflammatory and cytokine signaling, ECM organization and degradation, collagen metabolism, and chemical stress response. STRING analysis yielded a highly interconnected protein-protein interaction (PPI) network of 26 mapped nodes and 125 edges, with significant PPI enrichment (p < 1.0 × 10−16). Although MMP7 was not among the top global hubs, it was positioned within an ECM remodeling submodule involving MMP2, MMP9, TIMP1, CCN2, COL1A1, and TGFB1. Using the Felis catus MMP7 Reference Sequence (RefSeq) transcript XM_003992303.3, four coding sequence-targeting siRNA candidates were initially selected, and two were prioritized. MMP7-siRNA1 showed the most favorable overall profile, including a comparatively favorable Basic Local Alignment Search Tool (BLAST)-based specificity profile, stable duplex formation, low self-folding tendency, and high thermal stability. Together, these findings prioritize MMP7-siRNA1 as the primary candidate for experimental evaluation and support species-specific MMP7 targeting as a testable approach for investigating renal matrix remodeling in feline CKD.

🔖

Cite This Article

Vıcıl, S., Kırkulak, T. (2026). Network analysis and species-specific siRNA design targeting MMP7 in feline chronic kidney disease. Journal of advances in vetbio science and techniques, Issue: 2. https://doi.org/10.31797/vetbio.1945893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (27)

  1. Birmingham, A., Anderson, E. M., Reynolds, A., Ils¬ley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., Marshall, W. S., & Khvorova, A. (2006). 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nature Methods, 3(3), 199–204. https://doi.org/10.1038/ nmeth854
  2. Bonventre, J. V., & Yang, L. (2011). Cellular pathophys¬iology of ischemic acute kidney injury. The Journal of Clinical Investigation, 121(11), 4210–4221. https://doi. org/10.1172/JCI45161
  3. Brew, K., & Nagase, H. (2010). The tissue inhibitors of metal¬loproteinases (TIMPs): An ancient family with structural and functional diversity. Biochimica et Biophysica Acta — Molecular Cell Research, 1803(1), 55–71. https://doi. org/10.1016/j.bbamcr.2010.01.003
  4. Brown, C. A., Elliott, J., Schmiedt, C. W., & Brown, S. A. (2016). Chronic kidney disease in aged cats: Clin¬ical features, morphology, and proposed pathogene¬ses. Veterinary Pathology, 53(2), 309–326. https://doi. org/10.1177/0300985815622975
  5. Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Pap¬adopoulos, J., Bealer, K., & Madden, T. L. (2009). BLAST+: Architecture and applications. BMC Bioinfor¬matics, 10, 421. https://doi.org/10.1186/1471-2105-10- 421
  6. Chakrabarti, S., Syme, H. M., Brown, C. A., & Elliott, J. (2013). Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunc¬tion. Veterinary Pathology, 50(1), 147–155. https://doi. org/10.1177/0300985812453176
  7. Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.- T., & Lin, C.-Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Systems Biology, 8(Suppl 4), S11. https://doi. org/10.1186/1752-0509-8-S4-S11
  8. Cui, N., Hu, M., & Khalil, R. A. (2017). Biochemical and bi¬ological attributes of matrix metalloproteinases. Progress in Molecular Biology and Translational Science, 147, 1–73. https://doi.org/10.1016/bs.pmbts.2017.02.005
  9. International Renal Interest Society (IRIS). (2023). IRIS staging of CKD (modified 2023). Retrieved May 2026, from https://www.iris-kidney.com/iris-guidelines-1
  10. Ke, B., Fan, C., Yang, L., & Fang, X. (2017). Matrix metallo¬proteinases-7 and kidney fibrosis. Frontiers in Physiolo-gy, 8, 21. https://doi.org/10.3389/fphys.2017.00021
  11. Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., McDermott, M. G., Monteiro, C. D., Gundersen, G. W., & Ma’ayan, A. (2016). Enrichr: A comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Research, 44(W1), W90–W97. https://doi.org/10.1093/nar/gkw377
  12. Lawson, J., Elliott, J., Wheeler-Jones, C., Syme, H., & Jepson, R. (2015). Renal fibrosis in feline chronic kid¬ney disease: Known mediators and mechanisms of in¬jury. The Veterinary Journal, 203(1), 18–26. https://doi. org/10.1016/j.tvjl.2014.10.009
  13. Liu, Y. (2011). Cellular and molecular mechanisms of renal fibrosis. Nature Reviews Nephrology, 7(12), 684–696. https://doi.org/10.1038/nrneph.2011.149
  14. Lourenço, B. N., Coleman, A. E., Tarigo, J. L., Berghaus, R. D., Brown, C. A., Rissi, D. R., Stanton, J. B., Brown, S. A., & Schmiedt, C. W. (2020). Evaluation of profi¬brotic gene transcription in renal tissues from cats with naturally occurring chronic kidney disease. Journal of Veterinary Internal Medicine, 34(4), 1476–1487. https:// doi.org/10.1111/jvim.15801
  15. Markham, N. R., & Zuker, M. (2005). DINAMelt web serv¬er for nucleic acid melting prediction. Nucleic Acids Re¬search, 33(Web Server issue), W577–W581. https://doi. org/10.1093/nar/gki591
  16. Mimura, I., & Nangaku, M. (2010). The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease. Na¬ture Reviews Nephrology, 6(11), 667–678. https://doi. org/10.1038/nrneph.2010.124
  17. Nagase, H., Visse, R., & Murphy, G. (2006). Structure and function of matrix metalloproteinases and TIMPs. Car¬diovascular Research, 69(3), 562–573. https://doi. org/10.1016/j.cardiores.2005.12.002
  18. Naito, Y., Yoshimura, J., Morishita, S., & Ui-Tei, K. (2009). siDirect 2.0: Updated software for designing functional siRNA with reduced seed-dependent off-tar¬get effect. BMC Bioinformatics, 10, 392. https://doi. org/10.1186/1471-2105-10-392
  19. Reuter, J. S., & Mathews, D. H. (2010). RNAstructure: Software for RNA secondary structure prediction and analysis. BMC Bioinformatics, 11, 129. https://doi. org/10.1186/1471-2105-11-129
  20. Reynolds, B. S., & Lefebvre, H. P. (2013). Feline CKD: Pathophysiology and risk factors — what do we know? Journal of Feline Medicine and Surgery, 15(Suppl 1), 3–14. https://doi.org/10.1177/1098612X13495234
  21. Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., Moreno, J. A., Santamaria, B., Ruiz-Ortega, M., Egido, J., & Or¬tiz, A. (2010). NF-κB in renal inflammation. Journal of the American Society of Nephrology, 21(8), 1254–1262. https://doi.org/10.1681/ASN.2010020218
  22. Setten, R. L., Rossi, J. J., & Han, S.-P. (2019). The current state and future directions of RNAi-based therapeutics. Nature Reviews Drug Discovery, 18(6), 421–446. https:// doi.org/10.1038/s41573-019-0017-4
  23. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ide¬ker, T. (2003). Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Research, 13(11), 2498–2504. https://doi. org/10.1101/gr.1239303
  24. Sparkes, A. H., Caney, S., Chalhoub, S., Elliott, J., Finch, N., Gajanayake, I., Langston, C., Lefebvre, H. P., White, J., & Quimby, J. (2016). ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. Journal of Feline Medicine and Surgery, 18(3), 219–239. https://doi.org/10.1177/1098612X16631234
  25. Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Meh¬ryary, F., Hachilif, R., Gable, A. L., Fang, T., Donche¬va, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & von Mering, C. (2023). The STRING database in 2023: Protein–protein association networks and functional en¬richment analyses for any sequenced genome of interest. Nucleic Acids Research, 51(D1), D638–D646. https://doi. org/10.1093/nar/gkac1000
  26. Vlassara, H., Uribarri, J., Ferrucci, L., Cai, W., Torreg¬giani, M., Post, J. B., Zheng, F., & Striker, G. E. (2009). Identifying advanced glycation end products as a major source of oxidants in aging: Implications for the management and/or prevention of reduced renal function in elderly persons. Seminars in Nephrology, 29(6), 594– 603. https://doi.org/10.1016/j.semnephrol.2009.07.013
  27. Zhou, D., Tian, Y., Sun, L., Zhou, L., Xiao, L., Tan, R. J., Tian, J., Fu, H., Hou, F. F., & Liu, Y. (2017). Matrix metalloproteinase-7 is a urinary biomarker and patho¬genic mediator of kidney fibrosis. Journal of the Amer¬ican Society of Nephrology, 28(2), 598–611. https://doi. org/10.1681/ASN.2016030354